Osteoporosis treatment gap comes at a high price – The Pharmaceutical Journal

The Pharmaceutical JournalOsteoporosis treatment gap comes at a high priceThe Pharmaceutical JournalSecond, there are few osteoporosis specialists with advanced levels of expertise in managing patients with osteoporosis and bone mineral density (BMD) testing by dual-energy X-ray absorptiometry (DXA) is not universally available or affordable.and more

Source:: DXA Feed


Last modified: February 8, 2017